BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29739108)

  • 21. Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis.
    Zhi ML; Liu ZJ; Yi XY; Zhang LJ; Bao YX
    Genet Mol Res; 2015 Dec; 14(4):18018-25. PubMed ID: 26782449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examining plasma microRNA markers for colorectal cancer at different stages.
    Sun Y; Liu Y; Cogdell D; Calin GA; Sun B; Kopetz S; Hamilton SR; Zhang W
    Oncotarget; 2016 Mar; 7(10):11434-49. PubMed ID: 26863633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.
    Moridikia A; Mirzaei H; Sahebkar A; Salimian J
    J Cell Physiol; 2018 Feb; 233(2):901-913. PubMed ID: 28092102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare circulating microRNAs as biomarkers of colorectal neoplasia.
    Adams SV; Newcomb PA; Burnett-Hartman AN; Wurscher MA; Mandelson M; Upton MP; Zhu LC; Potter JD; Makar KW
    PLoS One; 2014; 9(10):e108668. PubMed ID: 25286412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.
    Clancy C; Joyce MR; Kerin MJ
    Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
    Perakis SO; Thomas JE; Pichler M
    Adv Exp Med Biol; 2016; 937():183-204. PubMed ID: 27573901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.
    Muhammad S; Kaur K; Huang R; Zhang Q; Kaur P; Yazdani HO; Bilal MU; Zheng J; Zheng L; Wang XS
    World J Gastroenterol; 2014 Dec; 20(45):17011-9. PubMed ID: 25493013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of miRNA as non-invasive biomarkers of colorectal cancer.
    Ren A; Dong Y; Tsoi H; Yu J
    Int J Mol Sci; 2015 Jan; 16(2):2810-23. PubMed ID: 25633103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
    Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
    Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers for Stratification in Colorectal Cancer: MicroRNAs.
    Fadaka AO; Pretorius A; Klein A
    Cancer Control; 2019; 26(1):1073274819862784. PubMed ID: 31431043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-level serum miR-24-2 is associated with the progression of colorectal cancer.
    He HW; Wang NN; Yi XM; Tang CP; Wang D
    Cancer Biomark; 2018 Feb; 21(2):261-267. PubMed ID: 29171985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives.
    Hernández R; Sánchez-Jiménez E; Melguizo C; Prados J; Rama AR
    BMB Rep; 2018 Nov; 51(11):563-571. PubMed ID: 30158023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor.
    Wan L; Kong J; Tang J; Wu Y; Xu E; Lai M; Zhang H
    J Cell Mol Med; 2016 Nov; 20(11):2036-2044. PubMed ID: 27307307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network.
    Zhu Y; Peng Q; Lin Y; Zou L; Shen P; Chen F; Min M; Shen L; Chen J; Shen B
    Oncotarget; 2017 Jan; 8(2):2233-2248. PubMed ID: 27903980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
    Yau TO; Wu CW; Tang CM; Chen Y; Fang J; Dong Y; Liang Q; Ng SS; Chan FK; Sung JJ; Yu J
    Oncotarget; 2016 Jan; 7(2):1559-68. PubMed ID: 26621842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.